CHI3L1 and breast carcinoma: In breast cancer patients, high levels of serum YKL-40 are associated with a poor prognosis (Jensen et al., 2003; Johansen et al., 2003; Kim et al., 2007; Yamac et al., 2008; Shao et al., 2011).